359 related articles for article (PubMed ID: 27262808)
1. Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts.
Sharifi-Rad M; Tayeboon GS; Sharifi-Rad J; Iriti M; Varoni EM; Razazi S
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):80-5. PubMed ID: 27262808
[TBL] [Abstract][Full Text] [Related]
2. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro.
Ademiluyi AO; Oboh G
Exp Toxicol Pathol; 2013 Mar; 65(3):305-9. PubMed ID: 22005499
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
Kwon YI; Jang HD; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
[TBL] [Abstract][Full Text] [Related]
4. Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro.
Ademiluyi AO; Oboh G
J Basic Clin Physiol Pharmacol; 2012 Jan; 23(1):17-25. PubMed ID: 22865445
[TBL] [Abstract][Full Text] [Related]
5. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
McCue P; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory potentials of phenolic-rich extracts from Bridelia ferruginea on two key carbohydrate-metabolizing enzymes and Fe
Afolabi OB; Oloyede OI; Agunbiade SO
J Integr Med; 2018 May; 16(3):192-198. PubMed ID: 29706572
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory Effect of Garlic, Purple Onion, and White Onion on Key Enzymes Linked with Type 2 Diabetes and Hypertension.
Oboh G; Ademiluyi AO; Agunloye OM; Ademosun AO; Ogunsakin BG
J Diet Suppl; 2019; 16(1):105-118. PubMed ID: 29522359
[TBL] [Abstract][Full Text] [Related]
9. Shaddock peels (Citrus maxima) phenolic extracts inhibit α-amylase, α-glucosidase and angiotensin I-converting enzyme activities: a nutraceutical approach to diabetes management.
Oboh G; Ademosun AO
Diabetes Metab Syndr; 2011; 5(3):148-52. PubMed ID: 22813568
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies of Gynura divaricata (L.) DC extracts as inhibitors of key enzymes relevant for type 2 diabetes and hypertension.
Wu T; Zhou X; Deng Y; Jing Q; Li M; Yuan L
J Ethnopharmacol; 2011 Jun; 136(2):305-8. PubMed ID: 21570455
[TBL] [Abstract][Full Text] [Related]
11. Potential of cranberry-based herbal synergies for diabetes and hypertension management.
Apostolidis E; Kwon YI; Shetty K
Asia Pac J Clin Nutr; 2006; 15(3):433-41. PubMed ID: 16837438
[TBL] [Abstract][Full Text] [Related]
12. Potentially antidiabetic and antihypertensive compounds identified from Pistacia atlantica leaf extracts by LC fingerprinting.
Ahmed ZB; Yousfi M; Viaene J; Dejaegher B; Demeyer K; Mangelings D; Vander Heyden Y
J Pharm Biomed Anal; 2018 Feb; 149():547-556. PubMed ID: 29190580
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension.
Kwon YI; Vattem DA; Shetty K
Asia Pac J Clin Nutr; 2006; 15(1):107-18. PubMed ID: 16500886
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome.
Hung WC; Ling XH; Chang CC; Hsu HF; Wang SW; Lee YC; Luo C; Lee YT; Houng JY
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065451
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant, α-Amylase and α-Glucosidase Inhibitory Activities and Potential Constituents of
Quan NV; Xuan TD; Tran HD; Thuy NTD; Trang LT; Huong CT; Andriana Y; Tuyen PT
Molecules; 2019 Feb; 24(3):. PubMed ID: 30744084
[TBL] [Abstract][Full Text] [Related]
16. Comparison of α-amylase, α-glucosidase and lipase inhibitory activity of the phenolic substances in two black legumes of different genera.
Tan Y; Chang SKC; Zhang Y
Food Chem; 2017 Jan; 214():259-268. PubMed ID: 27507474
[TBL] [Abstract][Full Text] [Related]
17. The in vitro evaluation of antioxidative activity, α-glucosidase and α-amylase enzyme inhibitory of natural phenolic extracts.
Djeridane A; Hamdi A; Bensania W; Cheifa K; Lakhdari I; Yousfi M
Diabetes Metab Syndr; 2015; 9(4):324-31. PubMed ID: 25470628
[TBL] [Abstract][Full Text] [Related]
18. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
Trinh BTD; Staerk D; Jäger AK
J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
[TBL] [Abstract][Full Text] [Related]
19. Leaf Extracts of
Akanji MA; Olukolu SO; Kazeem MI
Oxid Med Cell Longev; 2018; 2018():3439048. PubMed ID: 30356437
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition activity of polyphenol-rich extracts from Syzygium aromaticum (L.) Merr. & Perry (Clove) buds against carbohydrate hydrolyzing enzymes linked to type 2 diabetes and Fe(2+)-induced lipid peroxidation in rat pancreas.
Adefegha SA; Oboh G
Asian Pac J Trop Biomed; 2012 Oct; 2(10):774-81. PubMed ID: 23569846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
